---
title: "Pivotal trial of tricuspid annuloplasty system to commence following IDE approval"
date: "2025-10-16T09:52:43.000Z"
publishedDate: "16 octobre 2025"
summary: "Micro Interventional Devices has announced US Food &#38; Drug Administration (FDA) investigational device exemption (IDE) approval for its MIA-T annuloplasty system for the treatment of tricuspid annular disease. The approval will enable the commencement of a pivotal clinical trial—STTAR-US—of at several US hospitals."
importance: ""
sourceUrl: "https://cardiovascularnews.com/pivotal-trial-of-tricuspid-annuloplasty-system-to-commence-following-ide-approval/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2025-10-16-pivotal-trial-of-tricuspid-annuloplasty-system-to-commence-following-ide-approval"
imageUrl: "http://cardiovascularnews.com/wp-content/uploads/sites/14/2022/07/cath-lab-generic.jpeg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/pivotal-trial-of-tricuspid-annuloplasty-system-to-commence-following-ide-approval/"
---

![Pivotal trial of tricuspid annuloplasty system to commence following IDE approval](http://cardiovascularnews.com/wp-content/uploads/sites/14/2022/07/cath-lab-generic.jpeg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/pivotal-trial-of-tricuspid-annuloplasty-system-to-commence-following-ide-approval/*

## L’essentiel

Micro Interventional Devices has announced US Food &#38; Drug Administration (FDA) investigational device exemption (IDE) approval for its MIA-T annuloplasty system for the treatment of tricuspid annular disease. The approval will enable the commencement of a pivotal clinical trial—STTAR-US—of at several US hospitals.

## Lien source

https://cardiovascularnews.com/pivotal-trial-of-tricuspid-annuloplasty-system-to-commence-following-ide-approval/
